Preservation of human organs at subzero temperatures has been an elusive goal for decades. The major complication hindering successful subzero preservation is the formation of ice at temperatures below freezing. Supercooling, or subzero non-freezing, preservation completely avoids ice formation at subzero temperatures. We previously showed that rat livers can be viably preserved three times longer by supercooling as compared to hypothermic preservation at +4 °C. Scalability of supercooling preservation to human organs was intrinsically limited because of volume-dependent stochastic ice formation at subzero temperatures. However, we recently adapted the rat preservation approach so it could be applied to larger organs. Here, we describe a supercooling protocol that averts freezing of human livers by minimizing air–liquid interfaces as favorable sites of ice nucleation and uses preconditioning with cryoprotective agents to depress the freezing point of the liver tissue. Human livers are homogeneously preconditioned during multiple machine perfusion stages at different temperatures. Including preparation, the protocol takes 31 h to complete. Using this protocol, human livers can be stored free of ice at –4 °C, which substantially extends the ex vivo life of the organ. To our knowledge, this is the first detailed protocol describing how to perform subzero preservation of human organs.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Partial freezing of rat livers extends preservation time by 5-fold
Nature Communications Open Access 15 July 2022
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information files. Any additional data, if needed, will be provided upon request.
Giwa, S. et al. The promise of organ and tissue preservation to transform medicine. Nat. Biotechnol. 35, 530–542 (2017).
Buying time for transplants. Nat. Biotechnol. 35, 801 (2017).
de Vries, R. J., Yarmush, M. & Uygun, K. Systems engineering the organ preservation process for transplantation. Curr. Opin. Biotechnol. 58, 192–201 (2019).
Bruinsma, B. G. & Uygun, K. Subzero organ preservation: the dawn of a new ice age? Curr. Opin. Organ Transpl. 22, 281–286 (2017).
Pan, E. T. et al. Cold ischemia time is an important risk factor for post-liver transplant prolonged length of stay. Liver Transpl. 24, 762–768 (2018).
Usta, O. B. et al. Supercooling as a viable non-freezing cell preservation method of rat hepatocytes. PLoS ONE 8, e69334 (2013).
Berendsen, T. A. et al. Supercooling enables long-term transplantation survival following 4 days of liver preservation. Nat. Med. 20, 790–793 (2014).
Bruinsma, B. G. et al. Supercooling preservation and transplantation of the rat liver. Nat. Protoc. 10, 484–494 (2015).
Huang, H., Yarmush, M. L. & Usta, O. B. Long-term deep-supercooling of large-volume water and red cell suspensions via surface sealing with immiscible liquids. Nat. Commun. 9, 3201 (2018).
de Vries, R. J. et al. Supercooling extends preservation time of human livers. Nat. Biotechnol. 37, 1131–1136 (2019).
Fuller, B. J., Petrenko, A. & Guibert, E. Human organs come out of the deep cold. Nat. Biotechnol. 37, 1127–1128 (2019).
Guarrera, J. V. et al. Hypothermic machine preservation facilitates successful transplantation of “orphan” extended criteria donor livers: machine preservation of ECD livers. Am. J. Transpl. 15, 161–169 (2015).
Muller, X. et al. Can hypothermic oxygenated perfusion (HOPE) rescue futile DCD liver grafts? HPB 21, 1156–1165 (2019).
Schlegel, A. et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation. J. Hepatol. 70, 50–57 (2019).
Mergental, H. et al. Transplantation of declined liver allografts following normothermic ex-situ evaluation. Am. J. Transplant. 16, 3235–3245 (2016).
Ravikumar, R. et al. Liver transplantation after ex vivo normothermic machine preservation: a phase 1 (first-in-man) clinical trial. Am. J. Transplant. 16, 1779–1787 (2016).
Bral, M. et al. Preliminary single-center Canadian experience of human normothermic ex vivo liver perfusion: results of a clinical trial. Am. J. Transplant. 17, 1071–1080 (2017).
Watson, C. J. E. et al. Observations on the ex situ perfusion of livers for transplantation. Am. J. Transplant. 18, 2005–2020 (2018).
Nasralla, D. et al. A randomized trial of normothermic preservation in liver transplantation. Nature 557, 50–56 (2018).
Hoyer, D. P. et al. Controlled oxygenated rewarming of cold stored livers prior to transplantation: first clinical application of a new concept. Transplantation 100, 147–152 (2016).
de Vries, Y. et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution. Am. J. Transplant. 19, 1202–1211 (2019).
Bruinsma, B. G. et al. Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation: subnormothermic machine perfusion of human livers. Am. J. Transpl. 14, 1400–1409 (2014).
Bruinsma, B. G. et al. Metabolic profiling during ex vivo machine perfusion of the human liver. Sci. Rep. 6, 22415 (2016).
Sridharan, G. V. et al. Metabolomic modularity analysis (MMA) to quantify human liver perfusion dynamics. Metabolites 7, 58 (2017).
Karangwa, S. A. et al. Machine perfusion of donor livers for transplantation: a proposal for standardized nomenclature and reporting guidelines. Am. J. Transplant. 16, 2932–2942 (2016).
Baust, J. G., Gao, D. & Baust, J. M. Cryopreservation: an emerging paradigm change. Organogenesis 5, 90–96 (2009).
Pegg, D. E. Principles of cryopreservation. Methods Mol. Biol. 368, 39–57 (2007).
Finger, E. B. & Bischof, J. C. Cryopreservation by vitrification: a promising approach for transplant organ banking. Curr. Opin. Organ Transplant. 23, 353–360 (2018).
Fahy, G. M., Wowk, B. & Wu, J. Cryopreservation of complex systems: the missing link in the regenerative medicine supply chain. Rejuvenation Res 9, 279–291 (2006).
Manuchehrabadi, N. et al. Improved tissue cryopreservation using inductive heating of magnetic nanoparticles. Sci. Transl. Med. 9, eaah4586 (2017).
Storey, K. B. & Storey, J. M. Molecular biology of freezing tolerance. Compr. Physiol. 3, 1283–1308 (2013).
Dutheil, D., Underhaug Gjerde, A., Petit-Paris, I., Mauco, G. & Holmsen, H. Polyethylene glycols interact with membrane glycerophospholipids: is this part of their mechanism for hypothermic graft protection? J. Chem. Biol. 2, 39–49 (2009).
de Vries, R. et al. Extending the human liver preservation time for transplantation by supercooling. Transplantation 102, S396 (2018).
Vajdová, K., Graf, R. & Clavien, P.-A. ATP-supplies in the cold-preserved liver: a long-neglected factor of organ viability. Hepatology 36, 1543–1552 (2002).
Higashi, H., Takenaka, K., Fukuzawa, K., Yoshida, Y. & Sugimachi, K. Restoration of ATP contents in the transplanted liver closely relates to graft viability in dogs. Eur. Surg. Res. 21, 76–82 (1989).
Bruinsma, B. G. et al. Peritransplant energy changes and their correlation to outcome after human liver transplantation. Transplantation 101, 1637–1644 (2017).
Lanir, A. et al. Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology 8, 471–475 (1988).
Kamiike, W. et al. Adenine nucleotide metabolism and its relation to organ viability in human liver transplantation. Transplantation 45, 138–143 (1988).
op den Dries, S. et al. Ex vivo normothermic machine perfusion and viability testing of discarded human donor livers: normothermic perfusion of human livers. Am. J. Transpl. 13, 1327–1335 (2013).
Sutton, M. E. et al. Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PloS ONE 9, e110642 (2014).
Reiling, J. et al. Urea production during normothermic machine perfusion: price of success? Liver Transpl. 21, 700–703 (2015).
Funding from the US National Institutes of Health (R01DK096075, R01DK107875, R01DK114506 and R21EB023031) and the Department of Defense RTRP W81XWH-17-1-0680 and DHP SBIR H151-013-0141 is gratefully acknowledged. We thank Sylvatica Biotech, Inc., for collaboration and support through the NIH (R21EB023031) and the Department of Defense (DHP SBIR H151-013-0141). This work was partially supported by the Office of Assistant Secretary of Defense for Health Affairs, through the Reconstructive Transplant Research Program, Technology Development Award (under Award No. W81XWH-17-1-0680). The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. R.J.V. acknowledges support from the Tosteson Fellowship awarded by the Executive Committee on Research at the Massachusetts General Hospital and a stipend from the Michael van Vloten Fund for Surgical Research. S.N.T. acknowledges support from NIH K99 HL143149. We thank M. Karabacak, Y. M. Yu and F. Lin at the Mass Spectrometry Core Facility (Shriners Hospital for Children, Boston, Massachusetts) for assistance with adenylate quantification. We thank L. Burlage, A. Matton, B. Bruinsma and C. Pendexter for experimental assistance. Finally, appreciation is extended to LiveON NY, and we are especially grateful for our collaboration with New England Donor Services and their generous support that enables research with human donor organs.
M.T., M.L.Y., R.J.d.V., K.U. and S.N.T. have provisional patent applications relevant to this study. K.U. has a financial interest in Organ Solutions, a company focused on developing organ preservation technology. The authors’ interests are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies.
Peer review information Nature Protocols thanks Cyril Moers and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key reference using this protocol
de Vries, R. J. et al. Nat. Biotechnol. 37, 1131–1136 (2019): https://doi.org/10.1038/s41587-019-0223-y
Integrated supplementary information
Supplementary Figure 1 Design of custom glass perfusion chamber.
The perfusion chamber is custom made according to these drawings. Although the drawings are on scale, the dimensions are not critical and may vary as the part is hand-made from blown glass.
Supplementary Fig. 1.
Rights and permissions
About this article
Cite this article
de Vries, R.J., Tessier, S.N., Banik, P.D. et al. Subzero non-frozen preservation of human livers in the supercooled state. Nat Protoc 15, 2024–2040 (2020). https://doi.org/10.1038/s41596-020-0319-3
This article is cited by
Partial freezing of rat livers extends preservation time by 5-fold
Nature Communications (2022)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.